Neeraj Narula

83PUBLICATIONS
116CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oncology and carcinogenesis not elsewhere classifiedDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (83)

|Jun 26, 2026
The impact of global recruitment and country income on placebo rates in inflammatory bowel disease clinical trials.

|Apr 04, 2026
Efficacy and safety of ulcerative colitis therapies do not differ by age: A post hoc analysis of randomized controlled trials.

Emily C L Wong, John K Marshall, Christopher Ma

|Apr 03, 2026
An Enhanced Treatment Algorithm Targeting Mucosal Healing Is Effective and Safe in Older Patients With Crohn's Disease: A Post Hoc Analysis of the REACT2 Trial.

Shane W Goodwin, Sudheer Kumar Vuyyuru, Rocio Sedano

|Feb 02, 2026
Infliximab and Upadacitinib Demonstrate Superior Early Onset of Efficacy in Biologic-Naïve Ulcerative Colitis With Severe Endoscopic Disease.

Emily C L Wong, Vipul Jairath, Parambir S Dulai

|Dec 10, 2025
Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Remission in Ulcerative Colitis: An Open-Label Pilot Study.

Saad Syed, Paul Moayyedi, Dina Kao

|Nov 24, 2025
Serum and Histologic Eosinophilia as a Predictive Biomarker of Response to Mirikizumab in Ulcerative Colitis.

Emily C L Wong, Parambir S Dulai, John K Marshall

Pageof 14

Frequent Collaborators

21 joint publications

Emily C L Wong

15 joint publications

Christopher Ma

14 joint publications

Walter Reinisch

14 joint publications

Parambir S Dulai